Press Room

Share

Senate Appropriations Proposal Includes $2 Billion Funding Increase for NIH in FY 2021

November 10, 2020

Washington, D.C.,—Today the U.S. Senate released its FY 2021 spending bill that includes a $2 billion funding increase for the National Institutes of Health (NIH), including a $282 million funding boost for the National Cancer Institute (NCI). The proposal also includes the Henrietta Lacks Enhancing Cancer Research Act aimed at improving access to cancer research clinical trials for underrepresented communities of color.

A statement from Lisa Lacasse, president of the American Cancer Society Cancer Action Network (ACS CAN) follows:

“ACS CAN greatly appreciates the Senate’s recognition and prioritization of much-needed resources to the NIH and NCI during this critical time. The coronavirus pandemic has only emphasized the importance of robust biomedical research funding in maintaining and improving our nation’s health.

“It has also made clear the need to reduce health care disparities, including enabling greater access to clinical trials for communities of color. The Henrietta Lacks Enhancing Cancer Research Act would focus on identifying and removing barriers that prevent underrepresented groups from participating in cancer clinical trials and we are glad to see it included in this proposal.  Communities of color and other medically underserved groups continue to have higher cancer rates and are less likely to be diagnosed early or receive optimal treatment compared to other groups.

“We urge the Senate and House to consider broad research and prevention needs as they move ahead in this process and we look forward to working with them on a final appropriations agreement.”

More Press Releases AboutCancer Research Funding, National

Media Contacts

Allison Miller
Director, Media Advocacy
Washington, D.C.
[email protected]
202-585-3241
Alissa Crispino
Vice President, Media Advocacy & Communications
Washington, D.C.
[email protected]
202-661-5772

Related Press Releases

March 21, 2024

Congress Considers FY24 Appropriations Bill That Prioritizes Cancer Research and Proven Cancer Screening Funding Amidst Difficult Budget Cycle

WASHINGTON, D.C.— March 21, 2024 — Today, Congress released a series of spending bills aimed to finalize FY2024 funding that includes a $300 million increase in funding for the National Health Institute (NIH) base budget, including a $120 million increase in discretionary funding for the National Cancer Institute (NCI), a modest $500,000 increase for the Centers for Disease Control and Prevention (CDC) cancer screening and prevention programs and maintains the current funding level for the Advanced Research Projects Agency for Health (ARPA-H) at $1.5 billion. At NIH, the bill also includes a first-time appropriation of $12.5 million in dedicated funding for the development of palliative care research at NIH and a new $6 million initiative for Improving Native American Cancer Outcomes. Within the Department of Defense (DoD), the bill includes a $110 million for the Prostate Cancer Research Program. 

Read More
March 24, 2023

New Jersey is taking a giant leap forward in the war against cancer. Here's how

The following originally appeared in the Asbury Park Press on March 24, 2023.

 

Read more
March 11, 2024

President’s FY25 Budget Prioritizes Funding for Cancer Research and Prevention

The American Cancer Society Cancer Action Network (ACS CAN) is pleased to see President Biden’s continued focus on and dedication to achieving the goal of the Cancer Moonshot to end cancer as we know it, for everyone.

Read more